Form 4 for RMD ResMed|
Accepted 2024-09-10 00:00:00 ET · period of report 2024-09-09 · accession 0001127602-24-023758 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-10 | 2024-09-09 | RMD | Sandercock Brett | CFO | S - Sale | $246.42 | -1,000 | 96.8K | -1% | -$246.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-09-09 | S | D | 1,000 | $246.42 | 96,812 | D | — | — |